Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Treatment of chronic delta hepatitis with peglylated interferon

Next Previous
Trial Profile

Treatment of chronic delta hepatitis with peglylated interferon

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 03 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 28 May 2021 Long-term outcomes of patients with chronic hepatitis D after an extended course of peginterferon (n=12), were published in the Alimentary Pharmacology and Therapeutics.
  • 29 Jun 2012 Planned end date changed from 1 May 2012 to 1 Oct 2012 as reported by ClinicalTrials.gov.
  • 18 May 2010 Planned end date changed from 1 May 2010 to 1 May 2012 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top